![](/img/cover-not-exists.png)
MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit.
Sampson, J., Achrol, A.S., Aghi, M.K., Bankiewicz, K., Bexon, M., Brem, S., Brenner, A., Chowdhary, S., Coello, M., Ellingson, B.M., Floyd, J.R., Han, S., Kesari, S., Merchant, F., Merchant, N., RandaVolume:
138
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(20)31084-4
Date:
October, 2020
File:
PDF, 2.72 MB
2020